
Retina Technologies: Making vision screening accessible with portable, modular medical devices.
Retina Technologies was founded with the mission to make vision screening accessible through portable, modular medical devices. Their core product, OcuVue™, is an advanced digital vision screening technology designed to be simple, affordable, and comprehensive. The company aims to address the significant gap in vision care, particularly in areas lacking optometrists or ophthalmologists, by providing early detection and treatment solutions to prevent low vision and blindness.
Notable affiliated individuals include experts in ophthalmology and medical device engineering, who bring extensive experience to the company. Retina Technologies has attracted investment from leading venture capital firms focused on healthcare innovation. Key achievements include the successful development and deployment of OcuVue™ in underserved regions, significantly impacting early diagnosis rates. The overall impact of Retina Technologies is seen in its contribution to reducing preventable vision loss through accessible and effective screening solutions.

Intelligent Retinal Imaging Systems

Bioxytech Retina
bioxytech.com

Optovue

Ocutronics

Vitreoretinal Technologies

Retina-Ai Health

OcuSciences
ocusciences.com

Optain
optainhealth.com

Eyebot
eyebot.tech

EyeNetra
eyenetra.com

Sight Sciences
sightsciences.com

Opticent Health
opticenthealth.com

EyeCyte
eyecyte.com

OcuDoc
ocudocmobile.com

Ai-Ris
oculolabs.org
Companies similar to Retina Technologies include Intelligent Retinal Imaging Systems, Bioxytech Retina, Optovue and Ocutronics.
Retina Technologies was founded in 2018.
Retina Technologies' headquarters is located in New York City, NY, US.
Retina Technologies' most recent funding round was for $258k (USD) in May 2020.
As of May 11, 2020, Retina Technologies has raised a total of $333k (USD).
Retina Technologies has 8 employees as of Feb 5, 2024.